Neglected Tropical Disease Treatment Market Size, Share & Growth Report 2031
Neglected Tropical Disease Treatment Market Size, Share & Growth Report 2031
Segments - Global Neglected Tropical Disease Treatment Market by Disease Types (Mediterranean Fever, Ebola Virus Infection, Chagas Disease, Zika Virus Infection, Chikungunya, and Others), Treatment Types (Drugs [Analgesics, Antipyretics, Antibiotics, and Others], Vaccines[Dengvaxia, Mosquirix, and Others]), Routes of Administration (Oral and Injectable), End-users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecast, 2023-2031
Upcoming
| Report ID :HC-185
| 4.6 Rating
| 78 Reviews
| 165 Pages
| Format :
Report Description
Neglected Tropical Disease Treatment Market Outlook 2031
The global neglected tropical disease treatment market size was valued at USD 5.19 Billion in 2022 and is expected to reach USD 7.58 Billion by 2031 anticipated to expand at a substantial CAGR 4.3% during forecast period, between 2023 to 2031. Neglected tropical diseases are commonly seen in the areas where people do not have access to clean water or safe ways to dispose human waste.
Neglected tropical disease (NTD) refers to a heterogeneous and diverse group of communicable diseases that prevail in the subtropical and tropical conditions in around 149 countries. These diseases are caused by pathogens such as bacteria, protozoa, viruses, and helminthes. NTDs can be prevented by controlling the vectors transmitting diseases such as black flies and mosquitoes and by maintaining sanitation & hygiene. NTDs are concentrated in settings of extreme poverty in urban slums, remote rural areas, and conflict zones in Africa, Latin America, and Asia.
Neglected Tropical Disease Treatment Market Trends, Drivers, Restraints, and Opportunities:
- Rising government initiatives against NTDs is expected to boost the market during the forecast period.
- Growing burden of NTDs in tropical and subtropical countries globally is propelling the market growth.
- Low healthcare budget and limited operating revenue opportunities for research & development of targeted therapies are anticipated to impede the neglected tropical disease treatment market in the coming years.
- High demand for disease specific novel treatments is providing opportunities in the market.
Scope of The Neglected Tropical Disease Treatment Market Report:
The report on neglected tropical disease treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title |
Neglected Tropical Disease Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year |
2022 |
| Historic Data |
2016–2021 |
| Forecast Period |
2023–2031 |
| Segmentation |
By Disease Types (Mediterranean Fever, Ebola Virus Infection, Chagas Disease, Zika Virus Infection, Chikungunya, Others) By Treatment Types (Drugs (Analgesics, Antipyretics, Antibiotics, Others) Vaccine (Dengvaxia, Mosquirix, Others) By Routes of Administration (Oral, Injectable) By End-users (Hospitals, Homecare, Specialty Clinics, Others) By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Others) |
| Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
| Key Players Covered in the Report |
Emergent BioSolutionsInc, Moderna, Valneva SE, Johnson & Johnson Services, Inc, DAIICHI SANKYO COMPANY, LIMITED, InsudPharma group, Humanigen, Inc, Savant HWP, Inc, Bayer AG, Eisai Co., Ltd, Oblita Therapeutics, GlaxoSmithKline plc, Themis Bioscience GmbH, Novartis AG, and Amneal Pharmaceuticals LLC. |
Neglected Tropical Disease Treatment Market Segment Insights:
Rising R&D activities for Chagas disease treatment drives segment growth
In terms of disease types, the global neglected tropical disease treatment market can be categorized as Mediterranean fever, Ebola virus infection, Chagas disease, Zika virus infection, Chikungunya, and others. The Chagas disease segment held a substantial share of the market share in 2019 and is anticipated to expand at a moderate CAGR during the forecast period due to factors such as rising research activities for the development of Chagas disease treatments and growing occurrence of the disease owing to unhygienic conditions.
Moreover, approvals for novel products used to treat the disease are expected to propel segmental growth in the near future.
Presence of pipeline products to propel segmental growth
Based on treatment types, the market can be bifurcated into drugs and vaccine. The drugs segment is sub-divided into analgesics, antipyretics, antibiotics, and others. The vaccine segment is sub-segmented into dengvaxia, mosquirix, and others. The vaccines segment is anticipated to expand at a high CAGR during the forecast period owing to the presence of pipeline products and increasing focus of market players to develop vaccines for NTDs.
Awareness about the advantages of oral route of administration boosts segment growth
On the basis of routes of administration, the global neglected tropical disease treatment market can be classified as oral and injectable. The oral segment dominated the market in 2019 and is projected to expand at a high CAGR during the forecast period due patient compliance, ease of ingestion, pain avoidance, safety, and versatility to accommodate various types of drugs.
Access to a large patient pool in hospitals propels the segment
In terms of end-users, the market can be divided into hospitals, homecare, specialty clinics, and others. The hospitals segment is anticipated to expand at a substantial CAGR during the forecast period due to the availability of superior medical treatments for NTDs in hospitals. Moreover, hospitals provide cater to large patient pool.
Retail pharmacies segment accounts for a dominant share of the market
On the basis of distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, and others. Retail pharmacies segment is projected to be a lucrative segment of the market during the forecast period. In retail pharmacies, pharmacists interact with the patients to provide targeted counseling. This results in a better experience for the customer, hence most people tend to purchase their medications from retail pharmacy.
Asia Pacific is expected to account for a significant share of the global market
Based on regions, the global neglected tropical disease treatment market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific is expected to account for a large share of the market owing to factors such as continuously increasing GDP, presence of a large target population, and high prevalence of neglected tropical diseases in this region.
Segments
By Disease Types
- Mediterranean Fever
- Ebola Virus Infection
- Chagas Disease
- Zika Virus Infection
- Chikungunya
- Others
By Treatment Types
- Drugs
- Analgesics
- Antipyretics
- Antibiotics
- Others
- Vaccine
- Dengvaxia
- Mosquirix
- Others
By Routes of Administration
- Oral
- Injectable
By End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Emergent BioSolutionsInc
- Moderna, Valneva SE
- Johnson & Johnson Services,Inc
- DAIICHI SANKYO COMPANY
- LIMITED, InsudPharma group
- Humanigen,Inc
- Savant HWP Inc
- Bayer AG
- Eisai Co.Ltd
- Oblita Therapeutics
- GlaxoSmithKline plc
- Themis Bioscience GmbH
- Novartis AG
- Amneal Pharmaceuticals LLC.
Competitive Landscape
Key players in the global neglected tropical disease treatment market includes Emergent BioSolutionsInc, Moderna, Valneva SE, Johnson & Johnson Services, Inc, DAIICHI SANKYO COMPANY, LIMITED, InsudPharma group, Humanigen, Inc, Savant HWP, Inc, Bayer AG, Eisai Co., Ltd, Oblita Therapeutics, GlaxoSmithKline plc, Themis Bioscience GmbH, Novartis AG, and Amneal Pharmaceuticals LLC. Collaborations, mergers, acquisitions, agreements, and partnerships are strategies adopted by these players to strengthen their geographical presence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Neglected Tropical Disease Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neglected Tropical Disease Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neglected Tropical Disease Treatment Market - Supply Chain
4.5. Global Neglected Tropical Disease Treatment Market Forecast
4.5.1. Neglected Tropical Disease Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neglected Tropical Disease Treatment Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Neglected Tropical Disease Treatment Market Absolute $ Opportunity
5. Global Neglected Tropical Disease Treatment Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Homecare
5.3.3. Specialty Clinics
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Neglected Tropical Disease Treatment Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Neglected Tropical Disease Treatment Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
7. North America Neglected Tropical Disease Treatment Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Neglected Tropical Disease Treatment Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Homecare
7.4.3. Specialty Clinics
7.4.4. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
8. Latin America Neglected Tropical Disease Treatment Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Neglected Tropical Disease Treatment Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Homecare
8.4.3. Specialty Clinics
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
9. Europe Neglected Tropical Disease Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Neglected Tropical Disease Treatment Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Homecare
9.4.3. Specialty Clinics
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Neglected Tropical Disease Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Neglected Tropical Disease Treatment Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Homecare
10.4.3. Specialty Clinics
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Neglected Tropical Disease Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Neglected Tropical Disease Treatment Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Neglected Tropical Disease Treatment Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Homecare
11.4.3. Specialty Clinics
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Neglected Tropical Disease Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Neglected Tropical Disease Treatment Market: Market Share Analysis
12.2. Neglected Tropical Disease Treatment Distributors and Customers
12.3. Neglected Tropical Disease Treatment Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
Methodology
Related Reports
Some other reports from this category!
Our Clients
